Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
312.02
+0.62 (0.20%)
Dec 12, 2025, 4:00 PM EST - Market closed
Penumbra Market Cap
Penumbra has a market cap or net worth of $12.22 billion as of December 12, 2025. Its market cap has increased by 27.89% in one year.
Market Cap
12.22B
Enterprise Value
11.97B
1-Year Change
27.89%
Ranking
Category
Stock Price
$312.02
Market Cap Chart
Since September 18, 2015, Penumbra's market cap has increased from $1.23B to $12.22B, an increase of 891.59%. That is a compound annual growth rate of 25.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 12.22B | 34.07% |
| Dec 31, 2024 | 9.11B | -6.12% |
| Dec 29, 2023 | 9.71B | 14.91% |
| Dec 30, 2022 | 8.45B | -21.29% |
| Dec 31, 2021 | 10.73B | 68.92% |
| Dec 31, 2020 | 6.35B | 10.79% |
| Dec 31, 2019 | 5.74B | 36.03% |
| Dec 31, 2018 | 4.22B | 32.02% |
| Dec 29, 2017 | 3.19B | 58.19% |
| Dec 30, 2016 | 2.02B | 25.52% |
| Dec 31, 2015 | 1.61B | 30.52% |
| Sep 18, 2015 | 1.23B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |